🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to determine the change in blood pressure from the administra...
Status
Completed
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT00923091
Treatments Being Tested
This study is a double-blind randomized, placebo-controlled, parallel-group...
Status
Completed
Location
Research Site
Start Date
2015-09-01
Trial ID
NCT02354976
Treatments Being Tested
The purpose of this study is to determine whether lornoxicam or paracetamol...
Status
Unknown
Location
Diskapi Teaching and Research Hospital
Start Date
2010-02
Trial ID
NCT01069055
Treatments Being Tested
Zyclara™ (imiquimod) Cream, 3.75% is approved by the FDA for the treatment ...
Status
Completed
Location
Total Skin and Beauty Dermatology Center, PC
Start Date
2011-02
Trial ID
NCT01502020
Treatments Being Tested
Primary:To evaluate the efficacy of satavaptan on top of conventional treat...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2006-07
Trial ID
NCT00358878
Treatments Being Tested
The main purpose of this study is to evaluate the safety and tolerability o...
Status
Terminated
Location
Headlands Research - Scottsdale
Start Date
2025-07-21
Trial ID
NCT07085468
A Randomized, Double-Blind, Multicenter, phase III Study to Evaluate the An...
Status
Completed
Location
Severance Hospital
Start Date
2012-04
Trial ID
NCT01672476
Treatments Being Tested
Periodontitis is an infectious inflammatory disease affecting the periodont...
Status
Unknown
Location
Fatima Memorial Hospital
Start Date
2017-09-11
Trial ID
NCT03270280
Treatments Being Tested
The primary aim of this study is to clarify the position of FF and FF/Vilan...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-03-27
Trial ID
NCT02094937
To verify the superiority of celecoxib (YM177) 200 mg bid to placebo in tre...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2004-10
Trial ID
NCT00141154
Treatments Being Tested